Attached files
file | filename |
---|---|
10-Q - RegenoCELL Therapeutics, Inc. | v166190_10q.htm |
EX-31.1 - RegenoCELL Therapeutics, Inc. | v166190_ex31-1.htm |
Exhibit
32.1
REGENOCELL
THERAPEUTICS, INC.
CERTIFICATION
PURSUANT TO
18 U.S.C.
SECTION 1350
AS
ADOPTED PURSUANT TO SECTION 906
OF THE
SARBANNES-OXLEY ACT OF 2002
In connection with the quarterly
report of RegenoCELL Therapeutics, Inc. (the “Company”) on Form 10Q for the
quarter ended September 30, 2009 (the “Report”), I, James F. Mongiardo, Chief
Executive Officer and Chief Financial Officer of the Company, certify, pursuant
to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully
complies with the requirements of Section 13 (a) or 15 (d) of the Securities
Exchange Act of 1934; and
(2) The information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
/s/ | |
James
F. Mongiardo
|
|
Chief Executive Officer
|
|
and
|
|
November
13,
2009
|